Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · IEX Real-Time Price · USD
6.53
-0.01 (-0.15%)
Apr 17, 2024, 4:30 PM EDT - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lifecore Biomedical stock have an average target of 9.50, with a low estimate of 9.00 and a high estimate of 10. The average target predicts an increase of 45.48% from the current stock price of 6.53.
Analyst Consensus: Buy
* Price targets were last updated on Sep 1, 2023.
Analyst Ratings
The average analyst rating for LFCR stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +53.14% | Sep 1, 2023 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +37.83% | Sep 1, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +68.45% | Jun 2, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +53.14% | May 24, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +22.51% | Mar 21, 2023 |
Financial Forecast
Revenue This Year
127.91M
from 103.27M
Increased by 23.86%
Revenue Next Year
147.59M
from 127.91M
Increased by 15.39%
EPS This Year
-0.43
from -3.32
EPS Next Year
-0.14
from -0.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 131.7M | 151.9M | 169.4M |
| Avg | 127.9M | 147.6M | 164.6M |
| Low | 122.9M | 141.8M | 158.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 27.5% | 18.8% | 14.8% |
| Avg | 23.9% | 15.4% | 11.5% |
| Low | 19.0% | 10.9% | 7.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.44 | -0.15 | 0.09 |
| Avg | -0.43 | -0.14 | 0.09 |
| Low | -0.41 | -0.14 | 0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.